Skip to Content
Merck
  • Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.

Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.

Bioorganic & medicinal chemistry letters (2007-05-26)
Naohisa Ogo, Shinya Oishi, Kenji Matsuno, Jun-ichi Sawada, Nobutaka Fujii, Akira Asai
ABSTRACT

Inhibition of Eg5 represents a novel approach for the treatment of cancer. Here, we report the synthesis and structure-activity relationship of S-trityl-L-cysteine (STLC) derivatives as Eg5 inhibitors. Some of these derivatives such as 4f demonstrated enhanced inhibitory activity against Eg5 and induced mitotic arrest with characteristic monoastral spindles in HeLa cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Boc-Cys(Trt)-OH, 97%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
S-Methyl-L-cysteine, substrate for methionine sulfoxide reductase A
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
S-Carboxymethyl-L-cysteine
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Cysteine, 97%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Cysteine, from non-animal source, BioReagent, suitable for cell culture, ≥98%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
S-Benzyl-L-cysteine, 97%
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Cysteine, ≥97%, FG
SKU
Pack Size
Availability
Price
Quantity
SAFC
L-Cysteine
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Fmoc-Cys(Trt)-OH, ≥95.0% (sum of enantiomers, HPLC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
L-Cysteine, BioUltra, ≥98.5% (RT)
SKU
Pack Size
Availability
Price
Quantity